Skip to main content
Psyence Group Inc. logo

Psyence Group Inc. — Investor Relations & Filings

Ticker · PSYG ISIN · CA74449Q2053 LEI · 549300RPEOIVSD0MJC07 CSE Manufacturing
Open in API
Filings indexed 387 across all filing types
Latest filing 2021-11-18 Remuneration Information
Country CA Canada
Listing CSE PSYG

About Psyence Group Inc.

https://psyence.com/

Psyence Group Inc. is a science-led life science biotechnology company focused on the research, cultivation, and production of natural psychedelics and nature-based compounds. The company develops innovative, safe, and effective solutions for mental health. Its core clinical division, Psyence Therapeutics (now part of Psyence Biomedical Ltd.), pioneers the use of natural psilocybin formulations and treatment protocols, primarily targeting anxiety and depression within the context of palliative care. Supporting this effort, the company operates one of the world's first federally licensed, ISO22000 certified psilocybin cultivation and production facilities. Furthermore, Psyence Function markets a range of non-psychoactive functional mushroom wellness products utilizing adaptogens.

Recent filings

Filing Released Lang Actions
Other.pdf
Remuneration Information Classification · 95% confidence The document is a corrigendum replacing a page in a management information circular dated November 9, 2021. It discusses management service agreements, director and named executive officer compensation, and the role of the Board of Directors and Compensation Committee in determining compensation. The content focuses on governance and compensation details rather than financial results or regulatory filings. The document is not a full annual report, audit report, earnings release, or other financial report. It is not a proxy solicitation or voting results announcement but rather detailed information about management compensation and governance practices. Therefore, the document best fits the category of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors.
2021-11-18 English
Notice of the meeting and record date (amended) - English.pdf
Regulatory Filings Classification · 95% confidence The document is a short notice regarding the upcoming Annual General and Special Meeting of Psyence Group Inc., including details such as meeting date, record dates, and meeting format. It references proxy materials to follow but does not contain the actual meeting materials or detailed financial information. The document length is only 1574 characters, indicating it is an announcement rather than a full report. It fits the description of a Regulatory Filing (RNS) as a general regulatory announcement about the meeting and related procedural details, not the AGM materials themselves or voting results.
2021-10-15 English
News release - English.pdf
Regulatory Filings
2021-10-13 English
News release - English.pdf
Regulatory Filings
2021-10-12 English
News release - English.pdf
Regulatory Filings
2021-09-28 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended June 30, 2021. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references an interim report but does not include the report itself. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR). The document length is 3067 characters, which is relatively short and consistent with a certification letter rather than a full report.
2021-09-27 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.